Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Journal:
Current Neuropharmacology
Volume:
17
Page:
861-873
Author(s):
Marika Alborghetti and Ferdinando Nicoletti*
Clinical Characteristics and Possible Drug Targets in Autosomal Dominant Spinocerebellar Ataxias
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
18
Page:
279-293
Author(s):
Laszlo Szpisjak, Denes Zadori, Peter Klivenyi and Laszlo Vecsei*
Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
18
Page:
317-325
Author(s):
Mahmoud A. Ebada*, Souad Alkanj, Mohamed Ebada, Ahmed H. Abdelkarim, Ahmed Diab, Mohamed A.E. Aziz, Ahmed M. Soliman, Notila Fayed, Eshak I. Bahbah and Ahmed Negida
Prediction of Ropinirole Urine Level: An Application of the Adaptive-Network-Based Fuzzy Inference System (ANFIS) in Pharmaceutical Analysis
Journal:
Current Analytical Chemistry
Volume:
15
Page:
524-530
Author(s):
Mahnaz Qomi*, Marjan Gholghasemi, Farhad Azadi and Parviz Raoufi
Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
18
Page:
156-169
Author(s):
Mona H. Askar, Abdelaziz M. Hussein*, Soheir F. Al-Basiony, Refka K. Meseha, Emile F. Metias, Mohamed M. Salama, Ashraf Antar and Aya El-Sayed
Epigenetics in Neurodegenerative Diseases: The Role of Histone Deacetylases
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
18
Page:
11-18
Author(s):
Sorabh Sharma, K.C. Sarathlal and Rajeev Taliyan*
Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Journal:
Current Neuropharmacology
Volume:
17
Page:
247-267
Author(s):
Muneeb U. Rehman, Adil Farooq Wali, Anas Ahmad, Sheeba Shakeel, Saiema Rasool, Rayeesa Ali, Shazada Mudasir Rashid, Hassan Madkhali, Majid Ahmad Ganaie and Rehan Khan*
Neuroregeneration in Parkinson’s Disease: From Proteins to Small Molecules
Journal:
Current Neuropharmacology
Volume:
17
Page:
268-287
Author(s):
Yulia A. Sidorova*, Konstantin P. Volcho* and Nariman F. Salakhutdinov
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Journal:
Current Neuropharmacology
Volume:
17
Page:
295-306
Author(s):
Iván Carrera* and Ramón Cacabelos
Current Limitations in the Treatment of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers
Journal:
Current Medicinal Chemistry
Volume:
25
Page:
5755-5771
Author(s):
Chiara Tonda-Turo, Nicola Origlia, Clara Mattu, Alice Accorroni and Valeria Chiono*